Pure Health Holding PJSC

PUREHEALTHStocksAbu Dhabi Securities ExchangeHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Ratios

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	23.22B	28.33B	37.00B	63.33B	—
Market Cap Growth	-26.7%	-23.4%	-41.6%	—	—
Enterprise Value	33.76B	33.31B	42.51B	59.86B	—
Last Close Price	2.09	2.55	3.29	5.63	—
Valuation Multiples
Forward PE (Next 12M Est.)	10.13	14.57	—	—	—
PE Ratio	11.60	14.15	21.62	65.65	—
PS Ratio	0.85	1.04	1.43	3.86	—
PB Ratio	1.27	1.55	1.88	3.94	—
P/TBV Ratio	4.05	4.94	3.34	5.43	—
P/FCF Ratio	5.82	7.10	10.75	29.57	—
P/OCF Ratio	4.71	5.75	8.77	25.01	—
EV/Sales Ratio	1.24	1.22	1.64	3.65	—
EV/EBITDA Ratio	7.73	9.44	13.43	26.95	—
EV/EBIT Ratio	12.66	12.49	18.53	39.86	—
EV/FCF Ratio	8.46	8.35	12.35	27.95	—
Leverage & Capital
Debt / Equity Ratio	1.00	1.00	0.73	0.12	0.17
Debt / EBITDA Ratio	4.17	4.17	3.79	0.81	0.45
Debt / FCF Ratio	4.57	4.57	4.18	0.91	0.48
Net Debt / Equity Ratio	0.57	0.57	0.11	-0.56	-0.48
Net Debt / EBITDA Ratio	2.98	2.98	0.67	-4.03	-1.31
Net Debt / FCF Ratio	2.64	2.64	0.62	-4.18	-1.38
Efficiency & Liquidity
Asset Turnover	0.52	0.52	0.67	0.63	—
Inventory Turnover	15.83	15.83	19.95	19.34	—
Quick Ratio	1.15	1.15	1.66	2.00	1.37
Current Ratio	1.35	1.35	1.88	2.26	1.70
Returns & Yields
Return on Equity (ROE)	+10.6%	+10.6%	+9.6%	+7.0%	—
Return on Assets (ROA)	+3.2%	+3.2%	+3.7%	+3.6%	—
Return on Invested Capital (ROIC)	+8.8%	+9.5%	+15.3%	+16.1%	+66.1%
Return on Capital Employed (ROCE)	+6.3%	+6.3%	+6.3%	+7.5%	+26.3%
Earnings Yield	+8.6%	+7.1%	+4.6%	+1.5%	—
FCF Yield	+17.2%	+14.1%	+9.3%	+3.4%	—
Dividend Yield	+1.5%	—	+0.9%	—	—
Payout Ratio	+17.5%	+17.5%	—	+31.1%	+82.2%
Buyback Yield / Dilution	0.0%	0.0%	-10.7%	-2.1%	—
Total Shareholder Return	+1.5%	0.0%	-9.8%	-2.1%	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	23.22B	28.33B	37.00B	63.33B	—
Market Cap Growth	-26.7%	-23.4%	-41.6%	—	—
Enterprise Value	33.76B	33.31B	42.51B	59.86B	—
Last Close Price	2.09	2.55	3.29	5.63	—
Valuation Multiples
Forward PE (Next 12M Est.)	10.13	14.57	—	—	—
PE Ratio	11.60	14.15	21.62	65.65	—
PS Ratio	0.85	1.04	1.43	3.86	—
PB Ratio	1.27	1.55	1.88	3.94	—
P/TBV Ratio	4.05	4.94	3.34	5.43	—
P/FCF Ratio	5.82	7.10	10.75	29.57	—
P/OCF Ratio	4.71	5.75	8.77	25.01	—
EV/Sales Ratio	1.24	1.22	1.64	3.65	—
EV/EBITDA Ratio	7.73	9.44	13.43	26.95	—
EV/EBIT Ratio	12.66	12.49	18.53	39.86	—
EV/FCF Ratio	8.46	8.35	12.35	27.95	—
Leverage & Capital
Debt / Equity Ratio	1.00	1.00	0.73	0.12	0.17
Debt / EBITDA Ratio	4.17	4.17	3.79	0.81	0.45
Debt / FCF Ratio	4.57	4.57	4.18	0.91	0.48
Net Debt / Equity Ratio	0.57	0.57	0.11	-0.56	-0.48
Net Debt / EBITDA Ratio	2.98	2.98	0.67	-4.03	-1.31
Net Debt / FCF Ratio	2.64	2.64	0.62	-4.18	-1.38
Efficiency & Liquidity
Asset Turnover	0.52	0.52	0.67	0.63	—
Inventory Turnover	15.83	15.83	19.95	19.34	—
Quick Ratio	1.15	1.15	1.66	2.00	1.37
Current Ratio	1.35	1.35	1.88	2.26	1.70
Returns & Yields
Return on Equity (ROE)	+10.6%	+10.6%	+9.6%	+7.0%	—
Return on Assets (ROA)	+3.2%	+3.2%	+3.7%	+3.6%	—
Return on Invested Capital (ROIC)	+8.8%	+9.5%	+15.3%	+16.1%	+66.1%
Return on Capital Employed (ROCE)	+6.3%	+6.3%	+6.3%	+7.5%	+26.3%
Earnings Yield	+8.6%	+7.1%	+4.6%	+1.5%	—
FCF Yield	+17.2%	+14.1%	+9.3%	+3.4%	—
Dividend Yield	+1.5%	—	+0.9%	—	—
Payout Ratio	+17.5%	+17.5%	—	+31.1%	+82.2%
Buyback Yield / Dilution	0.0%	0.0%	-10.7%	-2.1%	—
Total Shareholder Return	+1.5%	0.0%	-9.8%	-2.1%	—